MorphoSys Announces Preliminary 2022 Monjuvi Revenue, Releases 2023 Financial Guidance and Reduces Financial Liability

MorphoSys Announces Preliminary 2022 Monjuvi Revenue, Releases 2023 Financial Guidance and Reduces Financial Liability

EQS-Ad-hoc: MorphoSys AG / Key word(s): ForecastAd hoc: MorphoSys AG announces preliminary Monjuvi sales for 2022, publishes financial guidance for 2023 and reduces financial liability 05.01.2023 / 11:33 CET/ESTPublication of …

Read more